drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
3D Systems advances bioprinting tech for ‘first-of-its-kind’ nerve repair
3D Systems announced that its 3D bioprinting technologies have enabled FDA approval for the regenerative repair of peripheral nerve damage. For the last several years, 3D Systems has partnered with TISSIUM, a French MedTech company that is a pioneer in the development of biomorphic programmable polymers for tissue reconstruction, to develop a bespoke 3D printing solution for the repair of damaged peripheral nerves. Combining TISSIUM’s expertise and proprietary biomorphic programable polymers with 3D Systems’ ground-breaking regenerative medicine bioprinting technologies has resulted in the successful development of a fully bioabsorbable 3D-printed medical device for nerve repair utilising a unique photopolymer. This device, called COAPTIUM CONNECT with TISSIUM Light, is a first-of-its-kind, atraumatic, sutureless solution for the repair of peripheral nerves. Earlier this week, TISSIUM announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorisation for this solution. This milestone validates the polymer’s clinical potential and paves the way for its use across a broad spectrum of transformative applications. Its unique polymer characteristics enable the production of high-resolution, elastomeric biodegradable implants that are unique in the industry.
Face Value: AI That Knows When You’re Too Tired to Drive
At U.K.-based Blueskeye AI, a team of facial expression analysts spends a lot of their time reviewing images of faces, tagging tiny nuances in muscle movement with meticulous precision. It could be a curl of the lip or a slightly raised eyebrow; either way, the high-quality, annotated data will be used to train facial recognition and emotion AI models. The Facial Action Coding System (FACS) annotator—also known as muscle action coder—isn’t a new concept. Developed by psychologists back in the 1970s, FACS is now a globally recognized tool to measure visual facial changes caused by muscle actions and thereby analyze the full range of human expression. What is new is the application of FACS annotation in software development for in-car monitoring systems designed to monitor driver behavior and detect signs of distraction, fatigue, and intoxication.
Harvesting Tears with the Power of Onions—House Foods Group Develops Tear Collection Kit
House Foods Group Headquarters is developing a “tear collection kit” that can be utilized as a new method for dry eye research and biomarker discovery using tears. This groundbreaking tool, applying the results of the company's long-term onion research, enables the induction and collection of natural tears at the required timing. The company previously achieved the world's first elucidation of the biosynthetic pathway for LF (Lachrymatory Factor), the tear-inducing component found in onions.LF is produced when two enzymes, Alliinase and LFS, act sequentially on the onion component PRENCSO as a substrate. This tear-inducing component LF is highly volatile and unstable, making it unsuitable for storage or use in its pure form. Consequently, the company developed a kit that mixes the enzymes and substrate immediately before use, enabling the generation of LF in the exact required amount when needed.Compared to conventional tear collection methods (capillary method or Schirmer test), this new technique reduces subject burden and reliably collects a sufficient volume of approximately 40μL of tears per sample. Its non-invasive nature is also highly regarded, making it suitable not only for ophthalmology but also for the growing field of tear-based biomarker research.Indeed, this kit is being utilized as a tool for tear biomarker discovery in a large-scale health screening project under Hirosaki University's COI program. Currently, the tear collection kit is in the preparatory stage for test marketing, with its initial market launch scheduled for fall 2025. Its application is anticipated not only in ophthalmic medicine but also in various fields, such as evaluating athlete training.
Music may reduce discomfort in patients with dementia
Anglia Ruskin University (ARU) and Cambridgeshire and Peterborough NHS Foundation Trusts have conducted a pilot study introducing music therapy for patients with dementia. The study adopted the MELODIC (Music Therapy in Everyday Life) approach and demonstrated positive effects on patients' quality of life and stress reduction. Additionally, this therapy is cost-effective and is considered a promising model for future research and practice.
Debut Launches Plant Cell Biotech Platform for Fragrance Ingredients Without Cultivation
On July 23, 2025, biotech company Debut announced the launch of its plant cell biotechnology platform that enables the creation of fragrance ingredients without cultivation. The company is launching the platform with its orris ingredient, inspired by the root of the iris flower. Named one of the Time100 Most Innovative Companies of 2025, Debut specializes in cutting-edge AI and biotechnology to deliver efficient and sustainable ingredients. The L’Oréal-backed startup replicates the molecular olfactive “fingerprint” of fragrance ingredients, allowing for supply chain reliability and ingredient consistency. Perfumer & Flavorist+ reached out to Debut’s founder and chief executive officer Joshua Britton to learn more about this biotechnology and where the company hopes to grow next.
ÄIO secures €1M to develop fermentation-based oils to replace palm and coconut oils
ÄIO, an Estonian biotech company, has secured €1 million in funding. The company develops sustainable, non-animal fats through fermentation. The funds will accelerate research and development. ÄIO aims to replace traditional oils used in cosmetics and chemicals. Its oils are vegan and environmentally friendly. The company was founded in 2022 as a spin-off from Tallinn University of Technology. It uses biomass and precision fermentation. The process reduces land use by 97% and water use by 90%, compared to palm oil. ÄIO offers an eco-conscious alternative to palm and coconut oil. Its oils also serve as a safer, bioactive option over petroleum-based mineral oils. The €1 million grant comes from the Estonian government’s Applied Research Programme. It supports a three-year project focused on fermentation-derived lipids. The total project budget is €1.8 million.
One in two people has a difference between actual sleep time and perceived sleep time 'imagined sleep' reality【Sleep survey of 125 people by Tokyo University startup】
Issin Co., Ltd., a healthcare startup originating from the University of Tokyo, conducted a survey on sleep visualization and its effects among 125 users of its “Smart Recovery Ring.” The results revealed that 54.0% of users reported a discrepancy between their perceived and actual sleep duration, with 34.0% confirming that their perceived sleep duration was shorter than their actual sleep duration. The survey also showed that many users began to review their sleep duration and make efforts to improve their lifestyle habits as a result of sleep visualization.Additionally, awareness of the relationship between sleep and weight management was low at 58.0%, highlighting the current lack of understanding regarding the importance of improving sleep quality. The survey also demonstrated that sleep visualization is having a ripple effect on overall lifestyle habits, and it is anticipated that this will serve as a catalyst for more people to prioritize health maintenance in the future.
Indoor greening technology using native plants - Creating indoor spaces where you can experience the changing seasons -
Our company has selected approximately 60 native plant species suitable for indoor cultivation through two years of indoor growth tests, focusing on species that naturally grow in regions with minimal annual temperature fluctuations, such as Okinawa in the southern part of Japan, and those found near our technical center. Additionally, by minimizing the exposed parts of stainless steel planters used for planting, we have developed an indoor greening technology called “T-Biophilic Green,” which replicates the natural form of outdoor environments and allows users to experience the changing seasons indoors.By applying this technology in a growth experiment (5 m²) conducted in the entrance hall of the technical center, the 61 species and 200 plants planted in February 2022 have maintained good growth rates and vegetation coverage as of August 2024. (See Figure 1)
Biophilic Urbanism Across Scales: Enhancing Urban Nature Through Experience and Design
As urban density increases and cities expand, there is a decrease in urban livability, which is closely linked to social, economic, and environmental crises. To address these negative impacts, biophilic urbanism (BU) promotes human–nature interactions and their associated benefits. However, knowledge gaps remain regarding its effectiveness across different scales. This study explores how BU contributes to improving livability in the built environment and to renewing urban landscapes. Using Amsterdam as a case study, we first identified biophilic experiences by analyzing them through quantitative, qualitative, and spatial distribution metrics. We then investigated designs that foster biophilia by applying BU tools aimed at enhancing interspecies connections and leveraging ecosystem services. Our findings, in the form of maps, provide evidence-based insights to benefit everyday life using nature in settings at different scales, along with design solutions to renew urban planning, focus on human and environmental well-being, and involve citizens in spatial transformations and maintenance processes. Finally, we advocate for BU as a holistic model that uses natural capital as a key strategy for making cities more equitable, sustainable, and resilient.
ViXion, developer of autofocus eyewear, to exhibit at China's largest nursing care and welfare exhibition
ViXion Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO: Seiichiro Nanbu; hereinafter referred to as “ViXion”), a company developing and selling autofocus eyewear “ViXion01S,” participated in “CHINA AID 2025,” China's largest welfare, care, and rehabilitation equipment exhibition, held in Shanghai, China, from June 11 (Wed) to 13 (Fri), 2025. Additionally, on June 12 (Thursday), during the official seminar “Japan's Experience × China's Speed: Breaking Through in the Senior Products Market through Japan-China Cooperation,” hosted by the Japan External Trade Organization (JETRO) within the same exhibition, Reimi Takeda, Global Business Division APAC Strategy and Business Development Manager responsible for the Chinese market, delivered a presentation on the global challenges of myopia and presbyopia and the company's technical approach to address these issues.
Smile Ball, the onion that doesn't make you cry—a new option born from 30 years of research
House Foods Group Headquarters Co., Ltd. is actively developing and marketing “Smile Ball,” a tear-free onion. This product is the result of over 30 years of research conducted by the company. In 2002, the company discovered a new enzyme, “LFS (Lachrymatory Factor Synthase),” which produces the tear-inducing component in onions.This research achievement garnered international attention, including winning the Ig Nobel Prize in Chemistry in 2013. This discovery led to the development of tear-free onions through the use of sudden mutation breeding techniques, which effectively eliminated the tear-inducing component. “Smile Ball” was launched in 2015. Since the tear-inducing component is also a spicy component, the onion can be eaten raw without soaking in water, making it highly regarded as an onion suitable for salads.Furthermore, in June 2025, a producer group was established in collaboration with onion producers in Hokkaido to ensure stable supply. The group aims to build a production system that can respond to recent weather fluctuations, ensuring both quality and quantity. Through this initiative, the company seeks to become a group trusted by intermediate distributors while also aiming to popularize onions that become a topic of conversation at family dinner tables.
Elucidation of vitamin C skin penetration pathways using 3D imaging
Menard Cosmetics Co., Ltd. (3-18-15 Marunouchi, Naka-ku, Nagoya, Aichi Prefecture, President and CEO: Junichi Nonokawa) has collaborated with the Forest Chemistry Laboratory, Graduate School of Life Sciences, Nagoya University(Nagoya City, Chikusa Ward, Furocho; Associate Professor: Dan Aoki) and the Aichi Industrial Science and Technology Research Institute (Aichi Prefecture) to develop a technology that enables imaging of how components used in cosmetics and pharmaceuticals penetrate the skin in a state closer to that of the living body and in three dimensions. This technology has now been successfully applied to analyze the three-dimensional penetration pathways of vitamin C applied to the skin into the skin's internal layers.
7 surefire ways to stimulate appetite and restore taste in older adults
Metabolism slows down, digestion becomes slower and less efficient. Heart failure and organ disease can alter food preferences and reduce appetite. Foods that once tasted good may now seem bland.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
3D Systems advances bioprinting tech for ‘first-of-its-kind’ nerve repair
3D Systems announced that its 3D bioprinting technologies have enabled FDA approval for the regenerative repair of peripheral nerve damage. For the last several years, 3D Systems has partnered with TISSIUM, a French MedTech company that is a pioneer in the development of biomorphic programmable polymers for tissue reconstruction, to develop a bespoke 3D printing solution for the repair of damaged peripheral nerves. Combining TISSIUM’s expertise and proprietary biomorphic programable polymers with 3D Systems’ ground-breaking regenerative medicine bioprinting technologies has resulted in the successful development of a fully bioabsorbable 3D-printed medical device for nerve repair utilising a unique photopolymer. This device, called COAPTIUM CONNECT with TISSIUM Light, is a first-of-its-kind, atraumatic, sutureless solution for the repair of peripheral nerves. Earlier this week, TISSIUM announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorisation for this solution. This milestone validates the polymer’s clinical potential and paves the way for its use across a broad spectrum of transformative applications. Its unique polymer characteristics enable the production of high-resolution, elastomeric biodegradable implants that are unique in the industry.
Medtech Insights
Face Value: AI That Knows When You’re Too Tired to Drive
At U.K.-based Blueskeye AI, a team of facial expression analysts spends a lot of their time reviewing images of faces, tagging tiny nuances in muscle movement with meticulous precision. It could be a curl of the lip or a slightly raised eyebrow; either way, the high-quality, annotated data will be used to train facial recognition and emotion AI models. The Facial Action Coding System (FACS) annotator—also known as muscle action coder—isn’t a new concept. Developed by psychologists back in the 1970s, FACS is now a globally recognized tool to measure visual facial changes caused by muscle actions and thereby analyze the full range of human expression. What is new is the application of FACS annotation in software development for in-car monitoring systems designed to monitor driver behavior and detect signs of distraction, fatigue, and intoxication.
EETimes
Harvesting Tears with the Power of Onions—House Foods Group Develops Tear Collection Kit
House Foods Group Headquarters is developing a “tear collection kit” that can be utilized as a new method for dry eye research and biomarker discovery using tears. This groundbreaking tool, applying the results of the company's long-term onion research, enables the induction and collection of natural tears at the required timing. The company previously achieved the world's first elucidation of the biosynthetic pathway for LF (Lachrymatory Factor), the tear-inducing component found in onions.LF is produced when two enzymes, Alliinase and LFS, act sequentially on the onion component PRENCSO as a substrate. This tear-inducing component LF is highly volatile and unstable, making it unsuitable for storage or use in its pure form. Consequently, the company developed a kit that mixes the enzymes and substrate immediately before use, enabling the generation of LF in the exact required amount when needed.Compared to conventional tear collection methods (capillary method or Schirmer test), this new technique reduces subject burden and reliably collects a sufficient volume of approximately 40μL of tears per sample. Its non-invasive nature is also highly regarded, making it suitable not only for ophthalmology but also for the growing field of tear-based biomarker research.Indeed, this kit is being utilized as a tool for tear biomarker discovery in a large-scale health screening project under Hirosaki University's COI program. Currently, the tear collection kit is in the preparatory stage for test marketing, with its initial market launch scheduled for fall 2025. Its application is anticipated not only in ophthalmic medicine but also in various fields, such as evaluating athlete training.
DxMedical Cloud™︎
Music may reduce discomfort in patients with dementia
Anglia Ruskin University (ARU) and Cambridgeshire and Peterborough NHS Foundation Trusts have conducted a pilot study introducing music therapy for patients with dementia. The study adopted the MELODIC (Music Therapy in Everyday Life) approach and demonstrated positive effects on patients' quality of life and stress reduction. Additionally, this therapy is cost-effective and is considered a promising model for future research and practice.
EurekAlert!
Debut Launches Plant Cell Biotech Platform for Fragrance Ingredients Without Cultivation
On July 23, 2025, biotech company Debut announced the launch of its plant cell biotechnology platform that enables the creation of fragrance ingredients without cultivation. The company is launching the platform with its orris ingredient, inspired by the root of the iris flower. Named one of the Time100 Most Innovative Companies of 2025, Debut specializes in cutting-edge AI and biotechnology to deliver efficient and sustainable ingredients. The L’Oréal-backed startup replicates the molecular olfactive “fingerprint” of fragrance ingredients, allowing for supply chain reliability and ingredient consistency. Perfumer & Flavorist+ reached out to Debut’s founder and chief executive officer Joshua Britton to learn more about this biotechnology and where the company hopes to grow next.
Perfumer & flavorist
ÄIO secures €1M to develop fermentation-based oils to replace palm and coconut oils
ÄIO, an Estonian biotech company, has secured €1 million in funding. The company develops sustainable, non-animal fats through fermentation. The funds will accelerate research and development. ÄIO aims to replace traditional oils used in cosmetics and chemicals. Its oils are vegan and environmentally friendly. The company was founded in 2022 as a spin-off from Tallinn University of Technology. It uses biomass and precision fermentation. The process reduces land use by 97% and water use by 90%, compared to palm oil. ÄIO offers an eco-conscious alternative to palm and coconut oil. Its oils also serve as a safer, bioactive option over petroleum-based mineral oils. The €1 million grant comes from the Estonian government’s Applied Research Programme. It supports a three-year project focused on fermentation-derived lipids. The total project budget is €1.8 million.
World Bio Market Insghts
One in two people has a difference between actual sleep time and perceived sleep time 'imagined sleep' reality【Sleep survey of 125 people by Tokyo University startup】
Issin Co., Ltd., a healthcare startup originating from the University of Tokyo, conducted a survey on sleep visualization and its effects among 125 users of its “Smart Recovery Ring.” The results revealed that 54.0% of users reported a discrepancy between their perceived and actual sleep duration, with 34.0% confirming that their perceived sleep duration was shorter than their actual sleep duration. The survey also showed that many users began to review their sleep duration and make efforts to improve their lifestyle habits as a result of sleep visualization.Additionally, awareness of the relationship between sleep and weight management was low at 58.0%, highlighting the current lack of understanding regarding the importance of improving sleep quality. The survey also demonstrated that sleep visualization is having a ripple effect on overall lifestyle habits, and it is anticipated that this will serve as a catalyst for more people to prioritize health maintenance in the future.
PR TIMES
Indoor greening technology using native plants - Creating indoor spaces where you can experience the changing seasons -
Our company has selected approximately 60 native plant species suitable for indoor cultivation through two years of indoor growth tests, focusing on species that naturally grow in regions with minimal annual temperature fluctuations, such as Okinawa in the southern part of Japan, and those found near our technical center. Additionally, by minimizing the exposed parts of stainless steel planters used for planting, we have developed an indoor greening technology called “T-Biophilic Green,” which replicates the natural form of outdoor environments and allows users to experience the changing seasons indoors.By applying this technology in a growth experiment (5 m²) conducted in the entrance hall of the technical center, the 61 species and 200 plants planted in February 2022 have maintained good growth rates and vegetation coverage as of August 2024. (See Figure 1)
大成建設
Biophilic Urbanism Across Scales: Enhancing Urban Nature Through Experience and Design
As urban density increases and cities expand, there is a decrease in urban livability, which is closely linked to social, economic, and environmental crises. To address these negative impacts, biophilic urbanism (BU) promotes human–nature interactions and their associated benefits. However, knowledge gaps remain regarding its effectiveness across different scales. This study explores how BU contributes to improving livability in the built environment and to renewing urban landscapes. Using Amsterdam as a case study, we first identified biophilic experiences by analyzing them through quantitative, qualitative, and spatial distribution metrics. We then investigated designs that foster biophilia by applying BU tools aimed at enhancing interspecies connections and leveraging ecosystem services. Our findings, in the form of maps, provide evidence-based insights to benefit everyday life using nature in settings at different scales, along with design solutions to renew urban planning, focus on human and environmental well-being, and involve citizens in spatial transformations and maintenance processes. Finally, we advocate for BU as a holistic model that uses natural capital as a key strategy for making cities more equitable, sustainable, and resilient.
MDPI
ViXion, developer of autofocus eyewear, to exhibit at China's largest nursing care and welfare exhibition
ViXion Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO: Seiichiro Nanbu; hereinafter referred to as “ViXion”), a company developing and selling autofocus eyewear “ViXion01S,” participated in “CHINA AID 2025,” China's largest welfare, care, and rehabilitation equipment exhibition, held in Shanghai, China, from June 11 (Wed) to 13 (Fri), 2025. Additionally, on June 12 (Thursday), during the official seminar “Japan's Experience × China's Speed: Breaking Through in the Senior Products Market through Japan-China Cooperation,” hosted by the Japan External Trade Organization (JETRO) within the same exhibition, Reimi Takeda, Global Business Division APAC Strategy and Business Development Manager responsible for the Chinese market, delivered a presentation on the global challenges of myopia and presbyopia and the company's technical approach to address these issues.
Vixion
Smile Ball, the onion that doesn't make you cry—a new option born from 30 years of research
House Foods Group Headquarters Co., Ltd. is actively developing and marketing “Smile Ball,” a tear-free onion. This product is the result of over 30 years of research conducted by the company. In 2002, the company discovered a new enzyme, “LFS (Lachrymatory Factor Synthase),” which produces the tear-inducing component in onions.This research achievement garnered international attention, including winning the Ig Nobel Prize in Chemistry in 2013. This discovery led to the development of tear-free onions through the use of sudden mutation breeding techniques, which effectively eliminated the tear-inducing component. “Smile Ball” was launched in 2015. Since the tear-inducing component is also a spicy component, the onion can be eaten raw without soaking in water, making it highly regarded as an onion suitable for salads.Furthermore, in June 2025, a producer group was established in collaboration with onion producers in Hokkaido to ensure stable supply. The group aims to build a production system that can respond to recent weather fluctuations, ensuring both quality and quantity. Through this initiative, the company seeks to become a group trusted by intermediate distributors while also aiming to popularize onions that become a topic of conversation at family dinner tables.
ハウス食品グループ本社株式会社
Elucidation of vitamin C skin penetration pathways using 3D imaging
Menard Cosmetics Co., Ltd. (3-18-15 Marunouchi, Naka-ku, Nagoya, Aichi Prefecture, President and CEO: Junichi Nonokawa) has collaborated with the Forest Chemistry Laboratory, Graduate School of Life Sciences, Nagoya University(Nagoya City, Chikusa Ward, Furocho; Associate Professor: Dan Aoki) and the Aichi Industrial Science and Technology Research Institute (Aichi Prefecture) to develop a technology that enables imaging of how components used in cosmetics and pharmaceuticals penetrate the skin in a state closer to that of the living body and in three dimensions. This technology has now been successfully applied to analyze the three-dimensional penetration pathways of vitamin C applied to the skin into the skin's internal layers.
PR TIMES
7 surefire ways to stimulate appetite and restore taste in older adults
Metabolism slows down, digestion becomes slower and less efficient. Heart failure and organ disease can alter food preferences and reduce appetite. Foods that once tasted good may now seem bland.
cap retraite